LONDON, July 27, 2026, 09:40 BST
London stocks were up on Monday, though the bulk of initial gains faded shortly after the open. By 09:40 BST, the FTSE 100 was ahead by 0.27% at 10,765.69, having started the session with a rise of 0.88%.
A decline in oil prices sends a strong signal to investors. Falling oil benefits consumers, airlines, and government bonds, while pressuring short-term revenue outlooks for top oil companies.
The FTSE 100 began the session 94.72 points higher than Friday’s finish. The increase then reduced to 29.46 points, trimming about 69% from the early rise. Mid-cap stocks fared comparatively better.
| Index | Level | Session move | Relative signal |
|---|---|---|---|
| FTSE 100 | 10,765.69 | +0.27% | Most early gains reversed |
| FTSE 250 | 23,944.58 | +0.60% | Mid-caps led performance |
| DAX | 25,438.47 | +1.38% | London trailed behind Germany |
Prices were noted between 09:25 and 09:40 BST and could reflect a delay. The FTSE 250 led blue-chip stocks by roughly 0.33 percentage points.
The divide was driven by oil. Brent dropped over 5% as U.S.-Iran hostilities eased. European travel stocks climbed 2.4%, but the energy sector declined 2%.
Shares of International Consolidated Airlines Group LON:IAG rose 3.7% at the open. BP LON:BP slipped nearly 3.4%, while Shell LON:SHEL dropped around 1.5%.
The disparity sheds light on London’s lagging performance. Lower fuel prices swiftly boost airline margins. However, for producers, the same trend reduces realised prices and projected cash flow.
Vodafone Group LON:VOD delivered notable gains among large-cap stocks, with shares advancing roughly 4%. The company reported a 5.2% rise in organic service revenue, while organic adjusted EBITDAaL climbed by 6.2%.
Chief Executive Margherita Della Valle pointed to “broad-based growth across all of our segments.” Vodafone anticipates earnings close to the higher end of its updated outlook. Vodafone
AstraZeneca LON:AZN climbed 1.6% following a second-quarter profit beat. Core earnings were up 18% at $2.63 a share, while revenue grew 5% to $15.38 billion.
Chief Executive Pascal Soriot stated that over “twenty high-value readouts” are expected in the next 18 months. AstraZeneca has maintained its forecast for 2026 and its $80 billion revenue ambition for 2030. The company’s shares are still roughly 8% down year-to-date. The Wall Street Journal
UK government bonds rallied as oil prices pulled back, with benchmark gilt yields sliding to their lowest level in a week. According to a Reuters survey, all 70 economists predict the Bank of England will keep its 3.75% rate unchanged on Thursday.
As a result, Monday’s trading supported a relative rotation rather than broad-based exposure to UK equities. Gains were stronger in mid-cap and travel sectors, reflecting oil price relief, while the FTSE 100, weighted towards energy stocks, saw smaller moves.
The upcoming BoE decision is the next key local event. Investors are looking to see if officials view the recent oil decline as lasting. A renewed jump in energy prices could swiftly restore worries over inflation and interest rates.
Risks stay elevated. This pause does not equate to a formal ceasefire, and Houthi attacks continue to pose a risk to regional energy assets. Any resumption of strikes could undo Monday’s advances in airlines, bonds, and mid-cap stocks.
